Author(s):
Vikas G. Pawar, Arshu Patel, Aarti R. Sanap
Email(s):
aartisanap773@gmail.com
DOI:
10.52711/2349-2988.2026.00026 
Address:
Vikas G. Pawar, Arshu Patel, Aarti R. Sanap
Pravara Rural College of Pharmacy, Loni, Ahilyanagar, Maharashtra, India.
*Corresponding Author
Published In:
Volume - 18,
Issue - 2,
Year - 2026
ABSTRACT:
Progressive neurodegenerative disorder i.e. Alzheimer’s disease (AD) is characterized by cognitive decline, oxidative stress, and cholinergic dysfunction, ß-amyloid aggregation, tau hyperphosphorylation. Plant-derived neuroprotective agents have gained increasing scientific attention due to their multi-target mechanisms and favorable safety profiles. This review aims to highlight the Alzheimer’s-suppressing potential of four traditionally important medicinal plants: Convolvulus pluricaulis, Curcuma longa, Withania somnifera, and Bacopa monnieri. C. pluricaulis has been reported to exhibit nootropic and anxiolytic effects mainly via cholinesterase inhibition and antioxidant activity. C. longa (Curcumin) has strong anti-amyloid, anti-inflammatory, and metal-chelating properties, offering protection against plaque formation and neuronal toxicity. W. somnifera (Withanolide) promotes synaptic regeneration, decreases oxidative stress, and provides amyloid and tau pathology modulation. B. monnieri, rich in bacosides and flavonoids, enhances cognitive performance by reducing oxidative damage, improving cholinergic function, and inhibiting ß-amyloid aggregation. Altogether, these botanicals act through complementary pathways, including antioxidant defense, anti-inflammatory modulation, neurotransmitter regulation, and prevention of amyloid/tau pathology, thereby making them promising candidates for the integrative management of AD. Further clinical validation is essential to determine standardized doses and the long-term efficacy of these extracts, as well as synergistic potential in combination therapies.
Cite this article:
Vikas G. Pawar, Arshu Patel, Aarti R. Sanap. Review on Alzheimer-Suppressing Potential of different Medicinal plant. Research Journal of Science and Technology. 2026; 18(2):185-9. doi: 10.52711/2349-2988.2026.00026
Cite(Electronic):
Vikas G. Pawar, Arshu Patel, Aarti R. Sanap. Review on Alzheimer-Suppressing Potential of different Medicinal plant. Research Journal of Science and Technology. 2026; 18(2):185-9. doi: 10.52711/2349-2988.2026.00026 Available on: https://rjstonline.com/AbstractView.aspx?PID=2026-18-2-9
REFERENCES:
1. Alzheimer's Disease International. World Alzheimer Report 2021: Journey through the diagnosis of dementia. London: Alzheimer's Disease International; 2021.
2. Nichols E, Steinmetz JD, Vollset SE, et al. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022; 7(2):e105-e125.
3. Scheltens P, De Strooper B, Kivipelto M, et al. Alzheimer's disease. Lancet. 2021; 397(10284):1577-1590.
4. Breijyeh Z, Karaman R. Comprehensive review on Alzheimer's disease: causes and treatment. Molecules. 2020; 25(24):5789.
5. Wimo A, Seeher K, Cataldi R, et al. The worldwide costs of dementia in 2019. Alzheimers Dement. 2023; 19(7):2865-2873.
6. Livingston G, Huntley J, Sommerlad A, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020; 396(10248):413-446.
7. Cummings J, Lee G, Ritter A, Sabbagh M, Zhong K. Alzheimer's disease drug development pipeline: 2020. Alzheimers Dement (N Y). 2020; 6(1):e12050.
8. Yiannopoulou KG, Papageorgiou SG. Current and future treatments in Alzheimer disease: an update. J Cent Nerv Syst Dis. 2020; 12:1179573520907397.
9. Birks JS, Harvey RJ. Donepezil for dementia due to Alzheimer's disease. Cochrane Database Syst Rev. 2018; 6(6):CD001190.
10. Pardridge WM. The blood-brain barrier: bottleneck in brain drug development. NeuroRx. 2005; 2(1): 3-14.
11. Gabathuler R. Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases. Neurobiol Dis. 2010; 37(1): 48-57.
12. Banks WA. From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery. Nat Rev Drug Discov. 2016; 15(4): 275-292.
13. Sethiya NK, Nahata A, Mishra SH, Dixit VK. An update on Shankhpushpi, a cognition-boosting Ayurvedic medicine. Zhong Xi Yi Jie He Xue Bao. 2009; 7(11): 1001-1022.
14. Malik J, Karan M, Vasisht K. Nootropic, anxiolytic and CNS-depressant studies on different plant sources of shankhpushpi. Pharm Biol. 2011; 49(12):1234-1242.
15. Bihaqi SW, Sharma M, Singh AP, Tiwari M. Neuroprotective role of Convolvulus pluricaulis on aluminium induced neurotoxicity in rat brain. J Ethnopharmacol. 2009; 124(3): 409-415.
16. Dhingra D, Valecha R. Evaluation of the antidepressant-like activity of Convolvulus pluricaulis choisy in the mouse forced swim and tail suspension tests. Med Sci Monit. 2007; 13(7): BR155-161.
17. Sharma K, Bhatnagar M, Kulkarni SK. Effect of Convolvulus pluricaulis Choisy and Asparagus racemosus Willd on learning and memory in young and old mice: a comparative evaluation. Indian J Exp Biol. 2010; 48(5): 479-485.
18. Nahata A, Patil UK, Dixit VK. Anxiolytic activity of Evolvulus alsinoides and Convolvulus pluricaulis in rodents. Pharm Biol. 2009; 47(5):444-451.
19. Rajput SB, Tonge MB, Karuppayil SM. An overview on traditional uses and pharmacological profile of Convolvulus pluricaulis Choisy. Curr Pharm Biotechnol. 2014; 15(4): 325-331.
20. Khoddami A, Wilkes MA, Roberts TH, Techniques for Analysis of Plant Phenolic Compounds. Molecules. 2013; 18(2): 2328-75.
21. Bhalerao, S. A., Verma, D. R., Teli, N. C., andTrikannad, A. A. Ethnobotany, phytochemistry and pharmacology of Convolvulus pluricaulis, Choisy. Res. J. Pharm. Biol. Chem. Sci. 2014; 5: 629–636.
22. Pan, R., Dai, Y., Gao, X., and Xia, Y. Scopolin isolated from Erycibe obtusifolia Benth stems suppresses adjuvant-induced rat arthritis by inhibiting inflammation and angiogenesis. Int. Immunopharmacol. 2009; 9: 859–869. doi: 10.1016/j.intimp.2009.02.019
23. Nisar, S. S., Khan, A.A., Maaz, M., andShiffa, M. Reviewof sankhahauli (Convolvulus pluricaulis choisy) from traditional medicine to modern science. Int. J. Institut. Pharm. Life Sci. 2012; 2: 94–101. Available at https://www.semanticscholar.org/ paper/REVIEW-OF-Sankhahauli-(Convolvulus-Pluricaulis from-Nisar-Khan/0994b296aed35c7b9ccaa97be1505fddf55218e8
24. Sethiya, N. K., Trivedi, A., Patel, M. B., and Mishra, S. H. Comparative pharmacognostical investigation on four ethanobotanicals traditionally used as Shankhpushpi in India. J. Adv. Pharm. Technol. Res. 2010; 1: 388–395. doi: 10.4103/ 0110-5558.76437
25. Bhutya, R. K. (2011). Ayurvedic medicinal plant of India (Jodhpur, India: Scientific Publishers).
26. Mishra, S. H., and Sethiya, N. K. Review on ethnomedicinal uses and phytopharmacology of memory boosting herb ‘Convolvulus pluricaulis' Choisy. Aust. J. Med. Herb. 2010; 22(1): 19–25. Available at https://www.semanticscholar. org/paper/Review-on-ethnomedicinal-uses-and-of-memory-herb-Sethiya Mishra/427692942318bd7bf5c9cd65e2cf8627aaa9c61f
27. Sultana, S., Ali, M., Mir, S. R., and Iqbal, D. Isolation and characterization of glycosides from Convolvulus prostratus, Ficus virens, Phoenix dactifera, Spondias mangifera and Terminalia belerica. Eur. J. Pharm. Med. Res. 2018; 5: 310 318. Available at https://pdfs.semanticscholar.org/696f/2e4d7280 727d2baba08bc7c6e3a7cd03ef3a.pdf
28. Singh, V. K., Govil, J. N., Hashmi, S., and Singh, G. (2003). Recent progress in medicinal plants: Ethnomedicine & Pharmacognosy II (Vol. 7) (Texas, USA: Studium Press).
29. Rizwan, M., and Khan, A. A. Assessment of efficacy of Sankhahuli (Convolvulus pluricaulis Chois.) and gokhru (Tribulus terrestris L.) in the management of hypertension. Indian J. Trad. Know. 2014; 13: 313–318. Available at http://nopr.niscair.res.in/handle/123456789/27919
30. Singh, V., and Pandey, R. P. Ethnobotany of Rajasthan (Jodhpur, India: Scientific Publishers). 1998.
31. Adams, M., Gmünder, F., and Hamburger, M. \Plants traditionally used in age related brain disorders—A survey of ethnobotanical literature. J. Ethnopharmacol. 2007; 113: 363–381. doi: 10.1016/j.jep.2007.07.016
32. Iloveindia.com. Shankapushpi. India: iloveindia.com; 2013. [Online] http://www.iloveindia.com/indian-herbs/shankapushpi.html. [Accessed on 8th Jully, 2013
33. Genchi, G.; Lauria, G.; Catalano, A.; Carocci, A.; Sinicropi, M.S. Neuroprotective Effects of Curcumin in Neurodegenerative Diseases. Foods 2024, 13, 1774. https://doi.org/10.3390/ foods13111774
34. https:// doi.org/10.1016/j.jep.2020.112769.
35. Basheer A, Agarwal A, Mishra B, Gupta A, Padma Srivastava MV, Kirubajaran R, Vishnu V Use of the Bacopa monnieriin in the treatment of Dementia to Alzheimer Disease: Systematic review of randomized controlled trials URL: https://www, i-jmr.org/2022/2/e3854
36. Bhattacharya, S.K., Kumar, A., Ghosal, S. Effects of glycowithanolides from Withania somnifera on an animal model of Alzheimer's disease and perturbed central cholinergic markers of cognition in rats. Phytother Res. 1995; 9 (2): 110–113.
37. Chaudhary, G., Sharma, U., Jagannathan, N.R., Gupta, Y.K. Evaluation of Withania somnifera in a middle cerebral artery occlusion model of stroke in rats. Clin. Exp. Pharmacol. Physiol. 2003; 30 (5–6): 399–404.
38. P. Agarwa, B. Sharma, A. Fatima, and S. K. Jain. An update on Ayurvedic herb Convolvulus pluricaulis Choisy. Asian Pacific Journal of Tropical Biomedicine. 2014; 4(3): 245–252.
39. N. K. Sethiya and S. H. Mishra. Review on ethnomedicinal uses and phytopharmacology of memory boosting herb Convolvulus pluricaulis Choisy. Australian Journal of Medical Herbalism. 2010; 22(1): 19–25.
40. B. Salehi, B. Krochmal-Marczak, D. Skiba et al. Convolvulus plant—a comprehensive review from phytochemical composition to pharmacy. Phytotherapy Research. 2020; 34(2): 315–328.
41. A. Balkrishna, P. Takur, and A. Varshney. Phytochemical profile, pharmacological attributes and medicinal properties of Convolvulus prostratus–a cognitive enhancer herb for the management of neurodegenerative etiologies. Frontiers in Pharmacology. 2020; 11: 171.
https://doi.org/10.1038/s41598-025-92644-y
42. https://www.pnas.org/doi/epdf/10.1073/pnas.1112209109
43. Park SY, Kim DS. Discovery of natural products from Curcuma longa that protect cells from beta-amyloid insult: A drug discovery effort against Alzheimers disease. J Nat Prod. 2002; 65: 1227-31.
44. Kim GY, Kim KH, Lee SH, Yoon MS, Lee HJ, Moon DO, Curcumin inhibits immunostimulatory function of dendritic cells: MAPKs and translocation of NF-B as potential targets. J Immunol. 2005; 174:8116-24
45. Kishore K, Singh M. Effect of bacosides, alcoholic extract of Bacopa monnieri Linn. (brahmi), on experimental amnesia in mice. Indian J Exp Biol. 2005; 43: 640–5.
46. Oyouni AAA, Saggu S, Tousson E, Mohan A, Farasani A. Mitochondrial nephrotoxicity induced by tacrolimus (FK-506) and modulatory effects of Bacopa monnieri (Farafakh) of Tabuk region. Pharmacognosy Res. 2019; 11. doi: 10.4103/pr.pr_100_18